Janssen, a pharmaceutical subsidiary of Johnson & Johnson, has announced plans to pursue a pediatric indication for its best-selling blood thinner, Xarelto (rivaroxaban).
Teresa McNulty
Advertisement
Articles by Teresa McNulty
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Permanent Daylight Saving Time could disrupt sleep and school performance in children, expert says
2
Rethinking screen time for back to school
3
Social media linked to riskier product use in teens
4
Dawn Dore-Stites, PhD, explains how permanent daylight saving time could affect children
5